Mounjaro vs Ozempic UK - Compare Prices & Effectiveness

Clinically Proven UK Registered Pharmacy

Mounjaro vs Ozempic - Compare Prices & Cheapest UK

Compare Mounjaro vs Ozempic at the cheapest UK price from £124.99 with £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£145.00 From £124.99 £20 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

Start Consultation

Mounjaro vs Ozempic: Which Weight Loss Treatment Is Right for You?

When comparing Mounjaro vs Ozempic, both medications have proven highly effective for weight loss in clinical trials, yet they work through distinct mechanisms and deliver different results. Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist, while Ozempic (semaglutide) targets GLP-1 receptors alone, and this fundamental difference influences their weight loss outcomes, side effect profiles, and suitability for individual patients. At Cured Pharmacy, our UK-registered clinical team helps patients navigate this choice with transparent pricing and expert guidance from superintendent pharmacist Tarun Kumar (GPhC 2233073).

Mounjaro vs Ozempic: How Do They Work Differently?

The core difference in the Mounjaro vs Ozempic debate lies in their receptor activity. Mounjaro (tirzepatide) activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, creating a dual-action mechanism that enhances insulin secretion, suppresses glucagon, and significantly reduces appetite[1]. Ozempic (semaglutide) works exclusively on GLP-1 receptors, delivering potent appetite suppression and improved glycaemic control through a single pathway[2].

This dual-agonist design gives Mounjaro a theoretical advantage in metabolic regulation, as GIP receptors influence fat metabolism and energy expenditure in ways that GLP-1 alone does not address. In clinical practice, this translates to Mounjaro often producing greater average weight loss than Ozempic, though both medications require gradual dose escalation and are subject to prescriber approval based on individual health profiles. Both treatments are administered as once-weekly subcutaneous injections and are licensed in the UK for type 2 diabetes management, with Mounjaro also holding specific weight management indications.

Mounjaro vs Ozempic Weight Loss Results: What the Evidence Shows

Head-to-head trial data provides the clearest picture when evaluating Mounjaro vs Ozempic for weight loss efficacy. The SURPASS-2 trial directly compared tirzepatide against semaglutide 1mg in adults with type 2 diabetes, revealing that participants on the highest tirzepatide dose (15mg) achieved an average weight reduction of 11.2kg over 40 weeks, compared to 5.7kg with semaglutide 1mg[1]. While this trial used the diabetes-indicated dose of semaglutide rather than the higher 2.4mg dose used in dedicated weight loss formulations like Wegovy, the results still demonstrate tirzepatide's superior weight loss potential.

In the broader STEP programme, semaglutide 2.4mg produced average weight loss of approximately 15% of initial body weight over 68 weeks in adults without diabetes[2]. Meanwhile, the SURMOUNT-1 trial showed tirzepatide 15mg delivering average weight reductions of 20.9% over 72 weeks in a similar population[3]. These figures represent averages from controlled trials, and individual results vary considerably based on adherence, lifestyle modifications, baseline weight, and metabolic factors. Both medications require ongoing use to maintain weight loss, and discontinuation typically results in weight regain.

Real-World Weight Loss Expectations

When patients ask about Mounjaro vs Ozempic outcomes in real-world settings, it's essential to set realistic expectations beyond trial averages. Clinical trials involve highly controlled conditions, regular monitoring, and participants selected for specific criteria, whereas everyday use involves varied adherence patterns and lifestyle contexts. Most patients on either medication can expect meaningful weight loss when combined with dietary modifications and increased physical activity, though the degree varies widely. Mounjaro users may experience slightly faster or greater weight reduction on average, but Ozempic remains highly effective and may be better tolerated by some individuals. All prescription weight loss treatments available through Cured Pharmacy require clinical assessment by a UK-registered prescriber to ensure suitability and safety.

Mounjaro vs Ozempic Side Effects: What to Expect

The side effect profiles in the Mounjaro vs Ozempic comparison are broadly similar, as both medications work through GLP-1 pathways that slow gastric emptying and influence appetite centres in the brain. The most commonly reported adverse effects for both treatments include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort, particularly during dose escalation phases[1][2]. These gastrointestinal symptoms typically diminish over several weeks as the body adapts, and they can be minimised by eating smaller meals, avoiding high-fat foods, and following the prescribed titration schedule carefully.

Some evidence suggests Mounjaro may produce slightly higher rates of gastrointestinal side effects compared to Ozempic, likely due to its dual-receptor activity, though the difference is modest and individual tolerance varies considerably[3]. Both medications carry warnings for rare but serious risks including pancreatitis, gallbladder disease, and thyroid C-cell tumours (observed in rodent studies but not conclusively demonstrated in humans). Neither medication is suitable for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Patients experiencing persistent vomiting, severe abdominal pain, or signs of pancreatitis should seek immediate medical attention and discontinue use pending clinical review.

Managing Side Effects Effectively

Practical management strategies can significantly reduce the impact of side effects when using either medication in the Mounjaro vs Ozempic choice. Starting at the lowest dose and increasing gradually every four weeks allows the digestive system to adjust, while staying well-hydrated and eating smaller, more frequent meals helps manage nausea. Avoiding alcohol, fatty foods, and large evening meals further reduces gastrointestinal discomfort. If side effects become intolerable, your prescriber may recommend pausing dose escalation or adjusting the titration schedule. At Cured Pharmacy, our clinical team provides ongoing support and can adjust treatment plans based on your individual response, ensuring both safety and tolerability throughout your weight loss journey.

Feature Mounjaro Ozempic
Active Ingredient Tirzepatide Semaglutide
Mechanism Dual GIP/GLP-1 agonist GLP-1 agonist
Dosing Frequency Once weekly injection Once weekly injection
Starting Dose 2.5mg weekly 0.25mg weekly
Maximum Dose 15mg weekly 1mg weekly (2.4mg for Wegovy)
Average Weight Loss Up to 20.9% (SURMOUNT-1) Up to 15% (STEP trials)
Common Side Effects Nausea, vomiting, diarrhoea Nausea, vomiting, diarrhoea
UK Price at Cured Pharmacy From £145.00 Varies by dose
Prescription Required Yes Yes

Mounjaro vs Ozempic Dosing and Administration

Both Mounjaro and Ozempic are administered as once-weekly subcutaneous injections, typically into the abdomen, thigh, or upper arm, making the practical administration aspect of the Mounjaro vs Ozempic decision relatively similar. Mounjaro is available in pre-filled single-dose pens at 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg strengths, with the standard initiation protocol starting at 2.5mg weekly for four weeks, then increasing to 5mg weekly, with further escalation to 7.5mg, 10mg, 12.5mg, or 15mg based on individual response and tolerability[1].

Ozempic dosing follows a similar gradual escalation approach, starting at 0.25mg weekly for four weeks (a non-therapeutic starter dose designed to improve tolerability), increasing to 0.5mg weekly, then potentially to 1mg weekly if additional glycaemic control or weight loss is needed[2]. For dedicated weight management, the higher-dose semaglutide formulation (Wegovy) escalates up to 2.4mg weekly. Both medications should be injected on the same day each week, though the specific day can be changed if needed provided at least 48 hours have elapsed since the last dose. Patients should rotate injection sites to reduce the risk of lipodystrophy and injection site reactions.

Mounjaro vs Ozempic UK Pricing and Availability

Price is often a decisive factor when patients evaluate Mounjaro vs Ozempic options in the UK. At Cured Pharmacy, Mounjaro is available from £124.99 per dose, with new patients receiving £20 off their first order using code Weightlossnew, bringing the initial cost to £124.99. Ozempic pricing varies by dose strength, and while both medications represent significant monthly investments, the cost must be weighed against the clinical benefits, tolerability, and individual treatment goals.

Both Mounjaro and Ozempic are prescription-only medicines in the UK, requiring clinical assessment by a registered prescriber before supply. While Ozempic is primarily licensed for type 2 diabetes management, it is sometimes prescribed off-label for weight loss at prescriber discretion. Mounjaro holds both diabetes and weight management indications, potentially offering broader prescribing flexibility. Availability of both medications has fluctuated due to global supply constraints, though Cured Pharmacy maintains reliable stock levels and transparent communication regarding any supply issues. All prices are displayed upfront before consultation, and our UK-registered clinical team completes assessments in under three minutes, with discreet next-day delivery available across the UK.

Long-Term Cost Considerations

When comparing Mounjaro vs Ozempic from a financial perspective, it's important to consider the long-term nature of weight loss treatment. Both medications require ongoing use to maintain weight loss, meaning monthly costs accumulate over extended periods. Some patients find that the potentially greater weight loss achieved with Mounjaro justifies the investment, while others achieve satisfactory results with Ozempic at a different price point. Insurance coverage and NHS availability vary, with neither medication routinely available for weight loss through the NHS except in very specific circumstances. Private prescriptions through registered UK pharmacies like Cured Pharmacy offer the most reliable access route, with transparent pricing and clinical oversight ensuring both safety and convenience.

Mounjaro vs Ozempic: Which Should You Choose?

The final decision in the Mounjaro vs Ozempic comparison depends on individual clinical factors, weight loss goals, tolerability, and budget considerations. Mounjaro may be the preferred choice for patients seeking maximum weight loss potential and who can tolerate the potentially higher rate of gastrointestinal side effects, while Ozempic offers proven efficacy with a well-established safety profile and may be better suited to those prioritising tolerability or working within tighter budget constraints[1][2].

Ultimately, neither medication is universally superior — the optimal choice varies by individual. Factors such as previous experience with GLP-1 medications, concurrent health conditions, medication interactions, and personal preferences all influence the decision. At Cured Pharmacy, our clinical assessment process evaluates your full medical history, current medications, and weight loss objectives to recommend the most appropriate treatment. Both Mounjaro and Ozempic require commitment to lifestyle modifications including dietary changes and regular physical activity to achieve optimal results, and ongoing monitoring by healthcare professionals ensures safety and effectiveness throughout treatment.

If you're ready to begin your weight loss journey with expert clinical support, transparent pricing, and genuine UK-licensed medications, Cured Pharmacy offers convenient online consultations with our registered prescribers. Start your assessment today to determine whether Mounjaro, Ozempic, or an alternative weight loss treatment is right for you, with the confidence of professional oversight from superintendent pharmacist Tarun Kumar and our experienced clinical team.

Scientific References

  1. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515.
  2. Wilding, J. P., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002.
  3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Which is more effective for weight loss, Mounjaro vs Ozempic?
Clinical trials suggest Mounjaro (tirzepatide) produces slightly greater average weight loss than Ozempic (semaglutide), with SURPASS-2 showing superior results and SURMOUNT-1 demonstrating up to 20.9% body weight reduction. Individual results vary based on adherence, lifestyle factors, and metabolic response.
Can I switch from Ozempic to Mounjaro or vice versa?
Switching between Mounjaro vs Ozempic is possible under prescriber guidance, typically involving a transition period to manage side effects and adjust dosing. Your UK-registered prescriber will determine the appropriate switching protocol based on your current dose and treatment response.
Are the side effects worse with Mounjaro vs Ozempic?
Both medications share similar gastrointestinal side effects including nausea, vomiting, and diarrhoea, though some evidence suggests Mounjaro may produce slightly higher rates due to its dual-receptor mechanism. Individual tolerance varies, and gradual dose escalation minimises discomfort with both treatments.
How quickly will I see results with Mounjaro vs Ozempic?
Most patients notice appetite reduction within the first few weeks on either medication, with measurable weight loss typically evident by 4-8 weeks. Maximum weight loss usually occurs after several months of treatment at the optimal maintenance dose, provided dietary and lifestyle modifications are maintained.
Is Mounjaro or Ozempic available on the NHS?
Both Mounjaro and Ozempic are available on NHS prescription for type 2 diabetes under specific criteria, but neither is routinely provided for weight loss alone except in very limited circumstances. Private prescriptions through registered UK pharmacies like Cured Pharmacy offer reliable access for weight management purposes.
Do I need to inject Mounjaro and Ozempic in the same way?
Yes, both medications are administered as once-weekly subcutaneous injections into the abdomen, thigh, or upper arm using pre-filled pens. Injection technique is identical, and both require rotation of injection sites to prevent lipodystrophy and maintain absorption consistency.
What happens if I stop taking Mounjaro or Ozempic?
Discontinuing either medication typically results in gradual weight regain, as the appetite-suppressing and metabolic effects diminish. Both treatments are intended for long-term use, and maintaining weight loss after stopping requires sustained lifestyle modifications including diet and exercise.
Can I take Mounjaro and Ozempic together?
No, Mounjaro and Ozempic should not be used together as they work through overlapping mechanisms and combining them significantly increases the risk of side effects without additional benefit. Your prescriber will recommend one medication based on your individual clinical profile and treatment goals.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 29 July 2026